Shanghai Kinlita Chemical Co., Ltd. (SHE:300225)
China · Delayed Price · Currency is CNY 9.06
-0.15 (-1.63%)
Jun 18, 2026, 3:04 PM CST
Shanghai Kinlita Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 836.94 | 792.2 | 715.75 | 718.19 | 616.84 | 832.64 |
Other Revenue | 10.41 | 10.41 | 15.79 | 16.55 | 16.07 | 25.32 |
| 847.35 | 802.6 | 731.54 | 734.74 | 632.91 | 857.96 | |
Revenue Growth (YoY) | 14.71% | 9.71% | -0.43% | 16.09% | -26.23% | -3.05% |
Cost of Revenue | 576.01 | 553.25 | 512.46 | 545.74 | 562.62 | 786.95 |
Gross Profit | 271.34 | 249.35 | 219.08 | 189 | 70.29 | 71.01 |
Selling, General & Admin | 163.03 | 159.97 | 137.05 | 126.51 | 152.45 | 159.31 |
Research & Development | 50.88 | 48.62 | 43.22 | 42.79 | 44.02 | 40.37 |
Other Operating Expenses | 2.7 | 2.45 | 2.35 | 0.65 | 3.4 | 1.36 |
Operating Expenses | 235.37 | 226.62 | 193.21 | 171.59 | 212.53 | 213.49 |
Operating Income | 35.97 | 22.73 | 25.87 | 17.41 | -142.24 | -142.48 |
Interest Expense | -4.4 | -5.13 | -5.56 | -3.05 | -0.28 | -1.18 |
Interest & Investment Income | 1.86 | 4.7 | 8.28 | 0.31 | 13.45 | 0.43 |
Currency Exchange Gain (Loss) | - | - | - | - | 0 | -0 |
Other Non Operating Income (Expenses) | -1.22 | -1.11 | 2.74 | 1.47 | -1.1 | -0.81 |
EBT Excluding Unusual Items | 32.2 | 21.18 | 31.33 | 16.14 | -130.16 | -144.04 |
Impairment of Goodwill | - | - | - | - | - | -3.85 |
Gain (Loss) on Sale of Investments | -0.19 | -0.19 | -0.29 | -0.53 | - | -0.13 |
Gain (Loss) on Sale of Assets | 0.12 | 0.56 | 0.05 | 0.42 | -0.15 | -0.23 |
Asset Writedown | -1.76 | 0.01 | -0.73 | - | -0.03 | -4.51 |
Other Unusual Items | 1.1 | 0.39 | 5.47 | 2.32 | 4.46 | 15.26 |
Pretax Income | 31.47 | 21.96 | 35.83 | 18.35 | -125.88 | -137.5 |
Income Tax Expense | 9.21 | 7.87 | 7.74 | 3.54 | -19.94 | -18.58 |
Earnings From Continuing Operations | 22.26 | 14.09 | 28.09 | 14.81 | -105.94 | -118.92 |
Minority Interest in Earnings | 3.41 | 2.83 | 2.82 | -0.48 | -0.09 | 8.26 |
Net Income | 25.67 | 16.92 | 30.91 | 14.33 | -106.02 | -110.66 |
Net Income to Common | 25.67 | 16.92 | 30.91 | 14.33 | -106.02 | -110.66 |
Net Income Growth | -24.30% | -45.26% | 115.66% | - | - | - |
Shares Outstanding (Basic) | 422 | 423 | 442 | 478 | 482 | 481 |
Shares Outstanding (Diluted) | 422 | 423 | 442 | 478 | 482 | 481 |
Shares Change (YoY) | -4.27% | -4.21% | -7.58% | -0.86% | 0.16% | 0.14% |
EPS (Basic) | 0.06 | 0.04 | 0.07 | 0.03 | -0.22 | -0.23 |
EPS (Diluted) | 0.06 | 0.04 | 0.07 | 0.03 | -0.22 | -0.23 |
EPS Growth | -20.92% | -42.86% | 133.33% | - | - | - |
Free Cash Flow | -15.77 | 25.91 | 98.64 | -21.1 | -204.33 | -231.85 |
Free Cash Flow Per Share | -0.04 | 0.06 | 0.22 | -0.04 | -0.42 | -0.48 |
Dividend Per Share | - | - | 0.020 | - | - | - |
Gross Margin | 32.02% | 31.07% | 29.95% | 25.72% | 11.11% | 8.28% |
Operating Margin | 4.25% | 2.83% | 3.54% | 2.37% | -22.47% | -16.61% |
Profit Margin | 3.03% | 2.11% | 4.23% | 1.95% | -16.75% | -12.90% |
Free Cash Flow Margin | -1.86% | 3.23% | 13.48% | -2.87% | -32.29% | -27.02% |
EBITDA | 57.87 | 45.53 | 52.29 | 50.84 | -108.28 | -109.42 |
EBITDA Margin | 6.83% | 5.67% | 7.15% | 6.92% | -17.11% | -12.75% |
D&A For EBITDA | 21.9 | 22.8 | 26.42 | 33.43 | 33.96 | 33.06 |
EBIT | 35.97 | 22.73 | 25.87 | 17.41 | -142.24 | -142.48 |
EBIT Margin | 4.25% | 2.83% | 3.54% | 2.37% | -22.47% | -16.61% |
Effective Tax Rate | 29.26% | 35.85% | 21.60% | 19.31% | - | - |
Revenue as Reported | 847.35 | 802.6 | 731.54 | 734.74 | 632.91 | 857.96 |
Advertising Expenses | - | - | - | - | 0.57 | 0.66 |